Accenture (NYSE:ACN – Get Free Report) had its target price upped by stock analysts at HSBC from $215.00 to $235.00 in a research report issued to clients and investors on Friday,MarketScreener reports. HSBC’s price objective indicates a potential downside of 12.91% from the company’s previous close. Other equities analysts also recently issued reports about the […]

Floor & Decor (NYSE:FND – Get Free Report) had its price objective cut by equities research analysts at Stifel Nicolaus from $92.00 to $90.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 47.44% […]

Matador Resources (NYSE:MTDR – Get Free Report) had its target price boosted by analysts at UBS Group from $46.00 to $50.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “neutral” rating on the energy company’s stock. UBS Group’s target price indicates a potential upside of 12.82% from the […]

HCA Healthcare (NYSE:HCA – Free Report) had its target price raised by Robert W. Baird from $423.00 to $450.00 in a report issued on Thursday,MarketScreener reports. The brokerage currently has a neutral rating on the stock. Several other research firms have also commented on HCA. Weiss Ratings reiterated a “buy (b)” rating on shares of […]

Home Depot (NYSE:HD – Get Free Report) had its target price cut by research analysts at Wolfe Research from $423.00 to $414.00 in a research report issued on Wednesday,MarketScreener reports. The brokerage presently has an “outperform” rating on the home improvement retailer’s stock. Wolfe Research’s target price would indicate a potential upside of 15.02% from […]

Ferguson (NYSE:FERG – Get Free Report) had its target price raised by equities researchers at Robert W. Baird from $262.00 to $265.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price target indicates a potential upside of 17.34% from the company’s […]

CONMED (NYSE:CNMD – Get Free Report) had its price objective lowered by stock analysts at Bank of America from $65.00 to $52.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Bank of America‘s price objective would indicate a potential upside of 29.47% from […]